Price$1.66-0.10 (-5.68%)
2026-03-192026-06-23
News · 26 weeks46+60%
2025-12-282026-06-21
Mix2990d
- Insider14(48%)
- SEC Filings9(31%)
- Other3(10%)
- Earnings2(7%)
- Leadership1(3%)
Latest news
25 items- INSIDERLarge owner Glenbrook Capital Management bought $13,563 worth of shares (8,264 units at $1.64) (SEC Form 4)4 - SenesTech, Inc. (0001680378) (Issuer)
- INSIDERSEC Form 4 filed by Director Moss Joshua Matthew4 - SenesTech, Inc. (0001680378) (Issuer)
- INSIDERSEC Form 4 filed by Director Leach Jacob Steven4 - SenesTech, Inc. (0001680378) (Issuer)
- INSIDERSEC Form 4 filed by Director Grandinetti Phillip Nicholas Iii4 - SenesTech, Inc. (0001680378) (Issuer)
- INSIDERSEC Form 4 filed by Director Szot Matthew K4 - SenesTech, Inc. (0001680378) (Issuer)
- INSIDERSEC Form 4 filed by CFO & Treasurer Chesterman Thomas C4 - SenesTech, Inc. (0001680378) (Issuer)
- INSIDERSEC Form 4 filed by Director Graham Lynn Yako4 - SenesTech, Inc. (0001680378) (Issuer)
- INSIDERSEC Form 4 filed by Director Morrison Jamie Bechtel4 - SenesTech, Inc. (0001680378) (Issuer)
- INSIDERSEC Form 4 filed by Chief Executive Officer Edell Michael4 - SenesTech, Inc. (0001680378) (Issuer)
- SECSenesTech Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - SenesTech, Inc. (0001680378) (Filer)
- INSIDERChief Executive Officer Edell Michael bought $1,550 worth of shares (1,000 units at $1.55), increasing direct ownership by 33% to 4,000 units (SEC Form 4)4 - SenesTech, Inc. (0001680378) (Issuer)
- INSIDERLarge owner Glenbrook Capital Management bought $45,536 worth of shares (28,389 units at $1.60) (SEC Form 4)4 - SenesTech, Inc. (0001680378) (Issuer)
- SECSEC Form DEFA14A filed by SenesTech Inc.DEFA14A - SenesTech, Inc. (0001680378) (Filer)
- PRSenesTech Expands Distribution of Evolve® Rodent Birth Control™ into BermudaSURPRISE, Ariz., June 4, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in birth control solutions for managing rodent populations, today announced the expansion of its Evolve® Rodent Birth Control™ products into Bermuda through a distribution agreement with Animal and Garden House, marking another step in the Company's growing presence in environmentally sensitive island markets. "Bermuda presents a unique environment for pest management solutions. As a small island with a dense population and close proximity between urban areas and surrounding marine ecosystems, the use of traditional rodenticides has long requi
- SECSEC Form DEFA14A filed by SenesTech Inc.DEFA14A - SenesTech, Inc. (0001680378) (Filer)
- PRSenesTech Announces Amendment to Equity Incentive Plan ProposalPHOENIX, June 3, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) ("SenesTech" or the "Company"), today announced that its Board of Directors has approved an amendment to the proposed changes to the Company's 2018 Equity Incentive Plan (the "2018 Plan"), which is being presented for stockholder approval at the Company's 2026 Annual Meeting of Stockholders scheduled for June 9, 2026. As previously disclosed in the Company's definitive Proxy Statement filed on April 29, 2026, stockholders are being asked to approve an amendment to the 2018 Plan to increase the number of shares available for future equity awards. Following furth
- SECSEC Form DEFA14A filed by SenesTech Inc.DEFA14A - SenesTech, Inc. (0001680378) (Filer)
- PRSenesTech to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026SURPRISE, Ariz., May 19, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2026 Investor Conference, taking place virtually on Thursday, May 28, 2026. Company WebcastThe webcast presentation will take place at 2:30 p.m. ET on Thursday, May 28, 2026. The webcast can be accessed by visiting the conference home page at http
- INSIDERLarge owner Glenbrook Capital Management bought $53,486 worth of shares (32,120 units at $1.67) (SEC Form 4)4 - SenesTech, Inc. (0001680378) (Issuer)
- INSIDERChief Executive Officer Edell Michael bought $5,013 worth of shares (3,000 units at $1.67) (SEC Form 4)4 - SenesTech, Inc. (0001680378) (Issuer)
- SECSenesTech Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - SenesTech, Inc. (0001680378) (Filer)
- PRSenesTech Reports Record Direct-to-Consumer and Subscription Growth Following Strategic E-Commerce TransitionIn-house e-commerce transition and new CEO expected to support scalable recurring revenue growth strategySURPRISE, Ariz., May 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products today announced financial results for the first quarter ended March 31, 2026 and provided an update on the Company's acceleration of revenue under newly appointed Chief Executive Officer, Michael Edell. Q1 2026 Financial HighlightsRevenue increased 2% to $493,
- PRSenesTech to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern timePHOENIX, May 7, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products, will report financial results for its first quarter 2026, ended March 31, 2026, after the market close on Tuesday, May 12, 2026. The Company has scheduled a conference call that same day, Tuesday, May 12, 2026, at 5:00 pm ET, to review the results. First Quarter
- SECSEC Form DEFA14A filed by SenesTech Inc.DEFA14A - SenesTech, Inc. (0001680378) (Filer)
- SECSenesTech Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - SenesTech, Inc. (0001680378) (Filer)
SNES FAQ
6 questionsWhat does SenesTech Inc. do?
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait that limits reproduction of male and female rats. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.Where does SNES stock trade?
SenesTech Inc. (SNES) is listed on NASDAQ.What sector and industry is SNES in?
SenesTech Inc. operates in the Industrials sector, Agricultural Chemicals industry.When did SenesTech Inc. go public?
SenesTech Inc. (SNES) completed its IPO in 2016.What companies are similar to SNES?
Notable peers in the same industry include NTR (Nutrien Ltd.), CF (CF Industries Holdings Inc.), MOS (Mosaic Company), ICL (ICL Group Ltd.), SMG (Scotts Miracle-Gro Company). Compare SNES side-by-side with any of them on Quantisnow.How can I track SNES on Quantisnow?
Quantisnow aggregates SenesTech Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SNES to receive live email and push alerts on every new disclosure.